Blood test may predict heart failure risk after viral infection

NCT ID NCT06742008

Recruiting now Knowledge-focused Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Source: ClinicalTrials.gov ↗

First seen Jan 06, 2026 · Last updated May 15, 2026 · Updated 17 times

Summary

This study looks at whether certain antibodies in the blood can predict if patients with acute viral myocarditis (heart inflammation caused by a virus) will develop dilated cardiomyopathy (a weakened, enlarged heart). Researchers will follow 300 patients over time, measuring these antibodies and tracking heart health. The goal is to find early warning signs that could lead to better monitoring and treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VIRAL MYOCARDITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
RECRUITING

Wuhan, Hubei, 430000, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

VIRAL MYOCARDITIS